Siemens wins FDA clearance for blood gas analyzer
March 31, 2020 -- Siemens Healthineers has garnered U.S. Food and Drug Administration (FDA) clearance for its RapidPoint 500e blood gas analyzer.
March 31, 2020 -- Siemens Healthineers has garnered U.S. Food and Drug Administration (FDA) clearance for its RapidPoint 500e blood gas analyzer.
Agilent launches liquid chromatography-mass spectrometry system in U.S.
March 30, 2020 -- Agilent Technologies has announced the U.S. launch of a new liquid chromatography-mass spectrometry system designed to improve diagnostic workflow in clinical laboratories.
March 30, 2020 -- Agilent Technologies has announced the U.S. launch of a new liquid chromatography-mass spectrometry system designed to improve diagnostic workflow in clinical laboratories.
Quidel receives expanded approval for COVID-19 test
March 27, 2020 -- The U.S. Food and Drug Administration has expanded Quidel's emergency use authorization for the company's Lyra SARS-CoV-2 assay, a real-time reverse transcription polymerase chain reaction test for the novel coronavirus.
March 27, 2020 -- The U.S. Food and Drug Administration has expanded Quidel's emergency use authorization for the company's Lyra SARS-CoV-2 assay, a real-time reverse transcription polymerase chain reaction test for the novel coronavirus.
Kalorama opens database of COVID-19 test instruments
March 26, 2020 -- Market research firm Kalorama Information has made available to hospitals and clinical labs a database that lists the installed base of diagnostic assay instruments that can perform tests for SARS-CoV-2 infection and COVID-19.
March 26, 2020 -- Market research firm Kalorama Information has made available to hospitals and clinical labs a database that lists the installed base of diagnostic assay instruments that can perform tests for SARS-CoV-2 infection and COVID-19.
Emerald Organic, Todos Medical team on COVID-19 tests
March 26, 2020 -- Emerald Organic Products and Todos Medical have created a joint venture to address the demand for COVID-19 screening and diagnostic testing in the U.S.
March 26, 2020 -- Emerald Organic Products and Todos Medical have created a joint venture to address the demand for COVID-19 screening and diagnostic testing in the U.S.
T2 adds coronavirus test to panels, per health network deal
March 25, 2020 -- T2 Biosystems has signed a worldwide licensing agreement for a rapid test developed by New Jersey-based Hackensack Meridian Health for SARS-CoV-2.
March 25, 2020 -- T2 Biosystems has signed a worldwide licensing agreement for a rapid test developed by New Jersey-based Hackensack Meridian Health for SARS-CoV-2.
CTK debuts 2 new coronavirus tests internationally
March 20, 2020 -- CTK has developed a polymerase chain reaction-based nucleic acid detection kit and a serological rapid screening test for use in detecting SARS-CoV-2, the virus that causes the respiratory disease COVID-19.
March 20, 2020 -- CTK has developed a polymerase chain reaction-based nucleic acid detection kit and a serological rapid screening test for use in detecting SARS-CoV-2, the virus that causes the respiratory disease COVID-19.
Abbott ships 150K coronavirus tests to U.S. hospitals
March 19, 2020 -- Abbott is shipping 150,000 tests for the novel coronavirus to hospitals and academic medical centers in the U.S., following the receipt of an emergency use authorization from the Food and Drug Administration.
March 19, 2020 -- Abbott is shipping 150,000 tests for the novel coronavirus to hospitals and academic medical centers in the U.S., following the receipt of an emergency use authorization from the Food and Drug Administration.
Spartan aims to deploy rapid, portable testing for COVID-19
March 19, 2020 -- Canadian biotechnology company Spartan Bioscience wants to use its rapid DNA testing platform to develop portable testing for the novel coronavirus.
March 19, 2020 -- Canadian biotechnology company Spartan Bioscience wants to use its rapid DNA testing platform to develop portable testing for the novel coronavirus.
Hologic secures emergency authorization for COVID-19 test
March 17, 2020 -- Medical technology company Hologic has garnered U.S. Food and Drug Administration emergency use authorization for its Panther Fusion SARS-CoV-2 molecular diagnostic test.
March 17, 2020 -- Medical technology company Hologic has garnered U.S. Food and Drug Administration emergency use authorization for its Panther Fusion SARS-CoV-2 molecular diagnostic test.